rs851821

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1778-16606G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.484 in 151,928 control chromosomes in the GnomAD database, including 17,975 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 17975 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.666

Publications

1 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1778-16606G>A intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.1778-16606G>A intron_variant Intron 11 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1778-16606G>A intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3
CNTNAP2ENST00000636870.1 linkn.1640-16606G>A intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1261-16606G>A intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1681-16606G>A intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.484
AC:
73530
AN:
151810
Hom.:
17941
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.469
Gnomad AMI
AF:
0.531
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.414
Gnomad EAS
AF:
0.602
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.456
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.502
Gnomad OTH
AF:
0.476
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.484
AC:
73608
AN:
151928
Hom.:
17975
Cov.:
32
AF XY:
0.479
AC XY:
35535
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.470
AC:
19450
AN:
41394
American (AMR)
AF:
0.445
AC:
6796
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
1435
AN:
3462
East Asian (EAS)
AF:
0.603
AC:
3102
AN:
5148
South Asian (SAS)
AF:
0.476
AC:
2293
AN:
4816
European-Finnish (FIN)
AF:
0.456
AC:
4811
AN:
10558
Middle Eastern (MID)
AF:
0.425
AC:
125
AN:
294
European-Non Finnish (NFE)
AF:
0.502
AC:
34103
AN:
67964
Other (OTH)
AF:
0.479
AC:
1009
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1952
3904
5856
7808
9760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.494
Hom.:
64095
Bravo
AF:
0.484
Asia WGS
AF:
0.524
AC:
1825
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.23
DANN
Benign
0.38
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs851821; hg19: chr7-147242624; API